BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
17.44
-0.62 (-3.43%)
Apr 28, 2026, 4:00 PM EDT - Market closed
BioAge Labs Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 774 | 474 | 208 | - | - |
| Market Cap Growth | 529.69% | 128.54% | - | - | - |
| Enterprise Value | 495 | 186 | -117 | - | - |
| Last Close Price | 17.44 | 13.23 | 5.79 | - | - |
| PS Ratio | 86.08 | 52.74 | - | - | - |
| PB Ratio | 2.40 | 1.74 | 0.64 | - | - |
| P/TBV Ratio | 2.85 | 1.74 | 0.64 | - | - |
| EV/Sales Ratio | 55.00 | 20.64 | - | - | - |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.03 | -1.31 | 0.12 |
| Net Debt / Equity Ratio | -1.03 | -1.03 | -1.07 | -0.78 | -1.25 |
| Net Debt / EBITDA Ratio | 3.02 | 3.02 | 4.43 | -0.65 | 0.63 |
| Net Debt / FCF Ratio | 3.40 | 3.40 | 6.66 | -0.84 | 0.69 |
| Asset Turnover | 0.03 | 0.03 | - | - | - |
| Quick Ratio | 14.06 | 14.06 | 12.80 | 0.37 | 4.72 |
| Current Ratio | 14.24 | 14.24 | 12.86 | 0.44 | 4.78 |
| Return on Equity (ROE) | -27.09% | -27.09% | -50.35% | - | - |
| Return on Assets (ROA) | -17.76% | -17.76% | -25.44% | -111.31% | - |
| Return on Capital Employed (ROCE) | -33.80% | -33.80% | -23.70% | 150.10% | -177.10% |
| Earnings Yield | -10.41% | -16.99% | -34.26% | - | - |
| FCF Yield | -10.63% | -17.36% | -25.00% | - | - |
| Buyback Yield / Dilution | -234.99% | -234.99% | -541.23% | -0.06% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.